Wilsele, Belgium

Joris Winderickx

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Fujirebio Europe N.v., Katholieke Universiteit Leuven. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joris Winderickx. Retrieved from https://idiyas.com/inventor/joris-winderickx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joris Winderickx: Innovator in Neurodegeneration Research

Introduction

Joris Winderickx is a notable inventor based in Wilsele, Belgium. He has made significant contributions to the field of neurodegeneration, particularly in relation to tau-related diseases and tauopathy. His innovative work has led to the development of valuable tools for research and diagnosis in this critical area of health.

Latest Patents

Winderickx holds a patent for "Antibodies to phosphorylated tau aggregates." This invention focuses on affinity tools for oligomeric forms of tau protein. It provides novel tau antibodies and antibody fragments, nucleic acids encoding such antibodies, and cell lines producing these antibodies. Additionally, the invention includes antibody compositions and kits for the detection of aggregated tau, as well as methods for diagnosing diseases involving aggregated tau. This work is crucial for identifying compositions that can interfere with the formation and stability of tau aggregates.

Career Highlights

Throughout his career, Winderickx has worked with several esteemed organizations. He has been associated with Katholieke Universiteit Leuven, where he contributed to academic research. He also worked with Ku Research & Development and Fujirebio Europe N.V., further enhancing his expertise in the field.

Collaborations

Winderickx has collaborated with notable colleagues, including Eugeen Vanmechelen and Fred Van Leuven. These partnerships have enriched his research and contributed to advancements in understanding tau-related diseases.

Conclusion

Joris Winderickx's innovative work in developing antibodies for tau aggregates represents a significant advancement in neurodegeneration research. His contributions are vital for the diagnosis and understanding of tau-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…